Royalty Pharma promises $500M to Teva for advancing vitiligo treatment
Royalty Pharma plc Class A Ordinary Shares · PHARMACEUTICAL PREPARATIONS · Now $55.18
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS